title: Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.
abstract: Cell production versus cell loss rates were estimated, across the boundaries of histological classification, in 50 cases of malignant non-Hodgkin's lymphomas by use of mitotic indices, percentage of Ki-67+ cells and percentage of PC10+ cells as proliferative indices, and the relative number of apoptotic bodies (apoptotic indices, AIs) as parameters. Regression analysis revealed significant (P < 0.01) positive correlations between the AIs and the proliferative indices; among the immunohistochemically assessed proliferative indices; and between these, the mitotic indices and the AIs on the one hand and histological malignancy grades on the other hand. The cellular protein BCL-2, which counteracts apoptosis, was significantly (P < 0.01) more often expressed in lymphomas with low than in those with high AIs. Multivariate analysis of data showed that of all parameters tested in this series, only the AIs correlated significantly (P < 0.05) with overall lethality. The correlation between BCL-2 positivity of lymphoma cells and overall survival did not quite attain significance (P = 0.08). Results of the present study suggest that high AIs and lack of BCL-2 expression may be adverse prognostic factors, independent of histological grade.
authors.affiliation: Institute of Pathologic Anatomy and Histology, University of Siena, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Leoncini
authors.forename: M T
authors.initials: MT
authors.lastname: Del Vecchio
authors.forename: T
authors.initials: T
authors.lastname: Megha
authors.forename: P
authors.initials: P
authors.lastname: Barbini
authors.forename: P
authors.initials: P
authors.lastname: Galieni
authors.forename: S
authors.initials: S
authors.lastname: Pileri
authors.forename: E
authors.initials: E
authors.lastname: Sabattini
authors.forename: F
authors.initials: F
authors.lastname: Gherlinzoni
authors.forename: P
authors.initials: P
authors.lastname: Tosi
authors.forename: R
authors.initials: R
authors.lastname: Kraft
mesh_terms: D017209:Apoptosis; D002455:Cell Division; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D019394:Ki-67 Antigen; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000401:mortality / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis; D009687:Nuclear Proteins / Q000032:analysis; D011518:Proto-Oncogene Proteins / Q000032:analysis; D019253:Proto-Oncogene Proteins c-bcl-2; D012044:Regression Analysis; D013194:Staining and Labeling; D016019:Survival Analysis
chemical_list: D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2